Ahmet Sezer - Concepedia

Author

Ahmet Sezer

University of Pittsburgh Medical Center ORCID

Also Known As

A Sezer, A. Sezer, Abdullah Sezer, Ahmet SEZER, Ahmet Sezer, Atakan Sezer, Bo Hu, ahmet sezer

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

University of Pittsburgh Medical Center Istanbul University-Cerrahpaşa Merck (Germany)Istanbul Medeniyet University Başkent University

About

Ahmet Sezer is an author at University of Pittsburgh Medical Center specializing in medicine, health sciences, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	205
2	Health Sciences	3	3	137
3	Engineering	1	1	92
4	Public Health	1	1	57
5	Biomedical Engineering	1	1	92

Ahmet Sezer

Publications

527

Citations

H-Index

Page 1

	Year	Citations
Lazertinib Versus Gefitinib as First-Line Treatment in Patients With <i>EGFR</i>-Mutated Advanced Non–Small-Cell Lung Cancer: Results From LASER301 Byoung Chul Cho, Myung‐Ju Ahn, Jin Hyoung Kang, Journal of Clinical Oncology	2023	122
Controlled release of piroxicam from chitosan beads Ahmet Sezer International Journal of Pharmaceutics Chitosan BeadsEngineeringBiotechnologyBiomedical EngineeringRelease Mechanism	1995	92
First-line cemiplimab monotherapy and continued cemiplimab beyond progression plus chemotherapy for advanced non-small-cell lung cancer with PD-L1 50% or more (EMPOWER-Lung 1): 35-month follow-up from a mutlicentre, open-label, randomised, phase 3 trial Mustafa Özgüroğlu, Ahmet Sezer, Mahmut Gümüş, The Lancet Oncology First-line Cemiplimab MonotherapyEmpower-lung 1MedicineCancer ManagementPd-l1 50	2023	82
Outcomes of Direct Oral Anticoagulants in Atrial Fibrillation Patients Across Different Body Mass Index Categories Amr F. Barakat, Sandeep Jain, Ahmad Masri, JACC. Clinical electrophysiology ThrombosisVenous ThrombosisDirect Oral AnticoagulantsCardiovascular DiseaseStroke	2021	57
Therapeutic modalities and clinical outcomes in a large cohort with LRBA deficiency and CTLA4 insufficiency Nigar Taghizade, Royala Babayeva, Altan Kara, Journal of Allergy and Clinical Immunology Primary ImmunodeficiencyTranslational MedicineAutoimmune DiseaseImmunodeficienciesImmunology	2023	36
Outcomes of catheter‐directed thrombolysis vs. standard medical therapy in patients with acute submassive pulmonary embolism Stephen D’Auria, Ahmet Sezer, Floyd Thoma, Pulmonary Circulation	2019	25
The impact of reoperative surgery on aortic root replacement in the United States Takuya Ogami, Derek Serna‐Gallegos, George J. Arnaoutakis, Journal of Thoracic and Cardiovascular Surgery	2023	21
Multiple Comparison of Age Groups in Bone Mineral Density under Heteroscedasticity Ahmet Sezer, Lale Altan, Özer Özdemir BioMed Research International AgingUnequal VarianceAge GroupsOsteoporosisBone Disease	2015	19
Bintrafusp Alfa With CCRT Followed by Bintrafusp Alfa Versus Placebo With CCRT Followed by Durvalumab in Patients With Unresectable Stage III NSCLC: A Phase 2 Randomized Study Everett E. Vokes, F. Mornex, Ahmet Sezer, Journal of Thoracic Oncology	2023	18
Avelumab Versus Platinum-Based Doublet Chemotherapy as First-Line Treatment for Patients With High-Expression Programmed Death-Ligand 1–Positive Metastatic NSCLC: Primary Analysis From the Phase 3 JAVELIN Lung 100 Trial Martin Reck, Fabrice Barlési, James C. Yang, Journal of Thoracic Oncology	2023	17

Page 1